Crawford & Company (NYSE:CRD.B) Downgraded by Zacks Investment Research

Zacks Investment Research cut shares of Crawford & Company (NYSE:CRD.B) from a hold rating to a sell rating in a report published on Thursday, Zacks.com reports.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

According to Zacks, “CRAWFORD & CO. is a worldwide diversified services firm organized which provides claims services, risk management services, disability managment, risk control services and risk management information services to insurance companies, self-insured corporations and governmental entities. “

Separately, ValuEngine upgraded Crawford & Company from a sell rating to a hold rating in a research note on Monday, September 30th.

Shares of Crawford & Company stock traded up $0.01 during midday trading on Thursday, hitting $9.66. The company had a trading volume of 9,367 shares, compared to its average volume of 27,341. The company has a debt-to-equity ratio of 1.40, a quick ratio of 1.32 and a current ratio of 1.31. The stock has a market capitalization of $490.16 million, a P/E ratio of 12.23 and a beta of 0.97. The company has a 50 day moving average of $9.54 and a 200 day moving average of $9.19. Crawford & Company has a 52-week low of $8.00 and a 52-week high of $10.56.

About Crawford & Company

Crawford & Company provides claims management and outsourcing solutions to the risk management and insurance industry, and self-insured entities. The company's Crawford Claims Solutions segment offers claims management services related to property, casualty, and catastrophe losses caused by physical damage to commercial and residential real properties, and personal properties, as well as marine losses.

Read More: How do taxes affect a CDs total return?

Get a free copy of the Zacks research report on Crawford & Company (CRD.B)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *

*